In contrast to healthy controls, the number of P2Y12+ homeostatic microglia is significantly reduced in the white matter of MS patients, and TMEM119+ microglia predominantly govern the edge of active lesions in MS (Zrzavy et al., 2017), indicating that microglial activation is related to disease development. Here, P2RY12 is linked to myeloid sarcoma.